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Abstract 
Previous studies have documented the presence of protein-mediated transport of UDP-glucuronic acid (UDP-GlcUA) in rat liver 
endoplasmic reticulum (ER). Measurement of uptake at varying concentrations of high specific activity [[3-32P]UDP-GlcUA has revealed 
the presence of a two component UDP-GlcUA transporting system. Transport at low substrate concentrations occurred predominantly via 
a high affinity component (K m = 1.6 ~M), whereas a low affinity component (K m = 38 ~M) predominated at high substrate 
concentrations. The K m for the high affinity system is in agreement with that previously published, while the low affinity component is a 
new finding. The uptake of UDP-GlcUA was temperature-sensitive, time dependent, and saturable for both components. The high affinity 
transport was affected by trans-stimulation and cis-inhibition by UDP-N-acetylglucosamine (UDP-GIcNAc); however, the same 
concentrations of UDP-GlcNAc had less effect on the low affinity system. In order to further study the two transport components, various 
inbibitors of anion transport carriers were tested. The high affinity component was strongly inhibited by 4-acetamido-4'-isothiocyanato- 
stilbene-2,2'-disulfonic a id (SITS) and furosemide, while the low affinity system was less sensitive to these reagents. Dose-dependent 
inhibition by 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS) was found for both transport systems. Probenecid was found to be 
a weak inhibitor of both components of the UDP-GIcUA uptake. Finally, the major metabolite of Y-azido-3'-deoxythymidine, 
3'-azido-3'-deoxythymidine monophosphate (AZTMP), was able to inhibit the uptake of UDP-GlcUA by both components. The results 
indicate the presence of two carrier-mediated UDP-glucuronic acid transporting components in rat liver ER. 
Keywords: UDP-glucuronic acid; Endoplasmic reticulum; Transport; Glucuronidation; (Rat liver) 
1. Introduction 
UDP-Glucuronosyltransferases (UGTs) are a family of 
enzymes involved in the biotransformation of exogenous 
compounds, such as drugs and other xenobiotics, and 
Abbreviations: AZT, Y-azido-Y-deoxythymidine; AZTMP, Y-azido- 
3'-deoxythymidine monophosphate; DIDS, 4,4'-diisothiocyanatostilbene- 
2,2'-disulfonic acid; ER, endoplasmic reticulum; SITS, 4-acetamido-4'- 
isothiocyanatostilbene-2,2'-disulfonic acid;UDP-GIcUA, UDP-glucuronic 
acid; UDP-GIc, UDP-glucose; UDP-Gal, UDP-galactose; UDP-GIcNAc, 
UDP-N-acetylglucosamine; UDP-Xyl, UDP-xylose; UGTs, UDP- 
glucuronosyltransferases 
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endogenous compounds, including bilirubin, steroid hor- 
mones, bile acids and thyroid hormones [1,2]. Hepatic 
glucuronidation occurs primarily in the endoplasmic reticu- 
lum (ER) of the hepatocyte and results in the conversion of 
hydrophobic ompounds to more hydrophilic species. Be- 
cause UDP-glucuronic acid (UDP-GlcUA), the essential 
co-substrate of UGTs, is synthesized from UDP-GIc by 
UDP-glucose dehydrogenase in the cytosol of the hepato- 
cyte and the active sites of the UGTs are lumenal in 
orientation [3-7], a mechanism presumably exists for the 
translocation of UDP-GlcUA from the cytosol to the ER 
lumen. A microsomal transport process for this highly 
hydrophilic substrate has been postulated for years [8-10]. 
Indeed, transport of UDP-GlcUA is an integral part of 
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detoxification, a fact that often receives less attention than 
the aforementioned biotransformations. 
The functional characterization of this UDP-GIcUA 
transporting system has been initiated recently by us and 
others. Bossyut et al. [11] employing dual-labeling and 
trans-stimulation experiments, demonstrated uptake of 
UDP-GlcUA into intact rat liver microsomal vesicles, con- 
sistent with bidirectional, carrier-mediated transport. This 
process was saturable, osmotically sensitive and inhibited 
by the protein-modifying reagent N-ethylmaleimide, sup- 
porting the involvement of a transmembrane protein carrier 
in this process. Our studies using a rapid filtration tech- 
nique provided additional evidence for saturable transport 
of [ J4C]UDP-GlcUA into an osmotically sensitive space of 
ER vesicles [12]. Moreover, uptake was found to be po- 
tently cis-inhibited and trans-stimulated by UDP-N- 
acetylglucosamine (UDP-GlcNAc). Additionally, GTP and 
Mg 2+ were found to be putative in vivo effectors of 
UDP-GIcUA transport [ 12]. A mechanism of stimulation of 
UGT activity by UDP-GlcNAc has recently been pro- 
posed. This model describes the interactions of two trans- 
port pathways, i.e., UDP-GlcUA influx coupled to UDP- 
GIcNAc efflux, and UDP-GlcNAc influx coupled to UMP 
effiux, combined with intravesicular metabolism of UDP- 
GIcUA [13]. We have reported the photoincorporation f 
[[3_ 32 P]5-azido-UDP-GIcUA ([13-3~p]5-N3-UDP-GlcUA) 
into the active site of UGTs as an indicator of UDP-GlcUA 
uptake into ER microsomal vesicles, consistent with the 
involvement of a membrane carrier with a cytoplasmic 
face sensitive to partial tryptic digestion [14]. The amount 
of information provided in the above studies is substantial. 
However, except for the UDP-GlcUA uptake experiments 
performed with a very low concentration f substrate [12], 
the kinetic parameters of the uptake process could not be 
resolved. For this reason, we have re-examined the kinetics 
of the uptake at varying concentrations u ing [32p]UDP- 
GIcUA. 
In this report, we have further characterized the carrier- 
mediated process of UDP-GIcUA transport into rat liver 
ER vesicles using a rapid filtration technique. The avail- 
ability of [[3- 32 p]UDP-GIcUA of high specific activity 
facilitated these studies of the initial rate of uptake over a 
wide range of substrate concentration. This approach led to 
the detection of two distinct components for the uptake of 
UDP-GlcUA in rat liver microsomes. We have character- 
ized both components by performing cis-inhibition and 
trans-stimulation experiments with various UDP-sugars 
and evaluating the effects of different reversible and irre- 
versible anion-transport inhibitors. 
2. Materials and methods 
2.1. Materials 
Uridine diphosphate glucuronic acid, [glucuronyl- 
14C(U)] (285.2 mCi/mmol) ([t4C]UDP-GlcUA) and uri- 
dine diphosphate galactose, [galactose-4,53H(U)] (30-50 
Ci/mmol) ([3H]UDP-galactose) were obtained from 
Dupont-NEN (Boston, MA). Filtron-X and Dimiscint were 
from National Diagnostics (Manville, NJ) and Soluene 350 
from Packard (Downers Grove, IL). 4,4'-diisothiocyana- 
tostilbene-2,2'-disulfonic acid (DIDS) and 4-acetamido-4'- 
isothiocyanatostilbene-2,2'-disulfonic acid (SITS) were 
from Molecular Probes (Eugene, OR). Uridine diphosphate 
glucuronic acid (UDP-GIcUA, triammonium salt), uridine 
diphosphate glucose (UDP-GIc, disodium salt), uridine 
diphosphate xylose (UDP-Xyl, sodium salt), uridine 
monophosphate (UMP, sodium salt) and UDP-N- 
acetylglucosamine (UDP-GlcNAc, sodium salt) were pur- 
chased from Sigma. 
2.2. Synthesis of  [ ~-~2 p]UDP-GlcUA 
[[3-32p]UDP-GIcUA was synthesized and purified as 
described for the synthesis of [[3-32 P]5N3UDP_GlcUA with 
UTP substituted for 5-azido-UTP [15]. [32P]P i was  from 
ICN (Irvine, CA). Conversion of [[3-32p]UDP-GIc to [[3- 
32p]UDP_GIcUA ranged from 70 to 100% with a specific 
activity of 5-10 mCi/txmol. 
2.3. Rat liver microsomal preparation 
Intact liver microsomes from male rats (Sprague-Daw- 
ley, 220-250 g) were prepared as previously described [3], 
except that they were not further subfractionated into 
rough and smooth ER fractions. The microsomal fraction 
was resuspended in 0.25 M sucrose, 1 mM MgCI 2, 10 mM 
HEPES, pH 7.4. Aliquots of microsomes were rapidly 
frozen in liquid nitrogen and stored at - 80°C. The protein 
concentration was determined by the Bradford method 
[16], using bovine serum albumin as the standard. The 
integrity of the microsomal vesicles was determined by a 
mannose-6-phosphatase l tency assay [17], with the modi- 
fications of Blair and Burchell [18]. Latency of the vesicles 
was consistently found to be greater than 95%. 
2.4. Marker enzyme activities 
Mannose-6-phosphatase activity was determined in liver 
homogenates and microsomal fractions. The enrichment of 
the enzyme in microsomes over the homogenate was typi- 
cally 3.4-fold, which is comparable to previously pub- 
lished values [13]. Na+/K + ATPase activity was assayed 
as described in [19] to detect any contamination of micro- 
somal preparations by plasma membranes. No detectable 
activity was found in the microsome preparations. The 
enzyme activity of UDP:galactose: ovomucoid galactosyl- 
transferase, a marker of the Golgi membranes, was as- 
sessed according to [20] with the modification of [21], 
using [3H]UDP-galactose. Liver homogenates and micro- 
somal fractions were first treated with 4 mM 3-[(3-chol- 
amidopropyl) dimethylammonio]-2-hydroxy-l-propane- 
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sulfonate (CHAPSO) on ice for 1 h [22] and enzyme 
activity was then determined. 
2.5. Transport measurements 
Uptake assays were performed as previously described 
[12] with the following modifications. The incubation 
medium contained rat liver microsomal vesicles (250 ixg 
protein) with the appropriate concentrations of either 
[14C]UDP_GlcUA or [[3- 32 P]UDP-GIcUA, as indicated in 
the figure legends, and uptake buffer (0.25 M sucrose, 1 
mM MgC12, 10 mM Tris-HC1, pH 7.4), in a final volume 
of 100 txl. The specific activity was typically in the range 
of 0.45 txCi/nmol and 0.24 IxCi/nmol, when the uptake 
of 5 jxM and 75 tzM [[3-32p]UDP-GlcUA, respectively, 
was examined. Uptake was initiated by the addition of rat 
liver microsomal vesicles to the uptake buffer, both of 
which had been preincubated at 25°C for 4 min. For 
experiments in which the initial rate of influx was mea- 
sured, uptake was terminated after 15 s by the addition of 
4 ml of an ice-cold 'stop' solution (0.25 M sucrose, 100 
mM NaCI, 1 mM MgC12, 10 mM Tris-HC1, pH 7.4). The 
diluted microsomes were filtered immediately through a 
0.22 ixm cellulose filter (Micron Separations) presoaked in
the same buffer containing 5 mM UDP-GIcUA using an 
ultrafiltration manifold (FH 225V, Hoefer Scientific Instru- 
ments) under vacuum, and the filter then washed with an 
additional 5 ml of 'stop' solution. Filters were dissolved in 
10 ml of Filtron-X (National Diagnostics) and counted 
using a LKB 1214 Rackbeta liquid scintillation spectrome- 
ter. The values of vesicle-incorporated ra ioactivity were 
corrected for non-specific binding, determined by adding 
the incubation medium to the ice-cold stop solution and 
filtering as above. 
2.6. Effect q]" osmolaritv on [ t4 C]UDP-GlcUA uptake 
Osmolarity studies were performed essentially as previ- 
ously described [11]. Briefly, intravesicular volume was 
modified by incubation of microsomes (250 [xg protein) 
for 15 rain at 37°C with the non-permeant trisaccharide 
raffinose (0-150 raM) in 0.25 M sucrose, 1 mM MgCI 2, 
10 mM Tris-HC1, pH 7.4. [HC]UDP-GlcUA was then 
added to a final concentration of 5 or 75 IxM and the 
incorporation of the radionuclide was determined, as de- 
scribed above, at equilibrium, previously established as 40 
min at 37°C. The concentration of raffinose in the 'stop' 
solutions was identical to that used in the incubation 
medium. The osmolarity of the solutions was determined 
using a vapor pressure osmometer (5100C, Wescor). 
0.1 and 1.0 raM. trans-Stimulation experiments were per- 
formed with these compounds by mechanically preloading 
the microsomal vesicles with the nucleotide sugars, as 
previously described [12], using the same concentrations 
used for the cis-inhibition studies (0.1 and 1.0 mM). The 
uptake for trans-stimulation experiments was evaluated 
following dilution of microsomes to 50 jxg protein per 
assay to reduce the external UDP-sugar concentration and, 
thus, the cis-inhibition. The initial rates of UDP-GIcUA 
influx were corrected for possible cis-inhibition of uptake 
by the residual external UDP-sugar, which was determined 
as follows. Briefly, the uptake was measured on control 
microsomes (no preloading) at an external UDP-sugar 
concentration range of 1.4 to 14.0 ixM, which corresponds 
to the external concentration that would exist during the 
trans-stimulation studies. 
2.8. hzhibitor studies 
The inhibitory potencies of furosemide, probenecid, 
AZT and AZTMP on the initial rate of uptake were 
evaluated by the external addition of these compounds to 
the microsomal vesicles. In control experiments, it was 
shown that 2% (v/v)  dimethyl sulfoxide, used to solubi- 
lize furosemide and probenecid, did not affect the initial 
uptake rate. The dose-dependent, irreversible inhibition by 
SITS and DIDS was determined by incubating the micro- 
somal vesicles (21.3 mg/ml  protein) with these com- 
pounds for 10 min at 25°C in 0.25 M sucrose, 1 mM 
MgC12, 10 mM Hepes, pH 7.4. Incubations were then 
diluted 10 times in 0.25 M sucrose, 1 mM MgCI 2, 10 mM 
Tris-HC1 pH 7.4 and initial uptake was measured. The 
degree of the inhibition is represented as a percentage of 
uptake activity compared to control experiments in which 
SITS or DIDS was omitted. 
The possible loss of vesicle integrity in the presence of 
inhibitors used in these studies was checked using the 
mannose-6-phosphatase l t ncy assay. Intact microsomes 
were treated with 1.2 mM SITS, 0.8 mM DIDS (the 
highest concentrations used for the determination of ICs0 
values; see Table 4), 1 mM probenecid or 2 mM furosemide 
and the mannose-6-phosphatase activity was measured and 
compared to that of untreated microsomes. No effect of the 
anion transport inhibitors was observed on the mannose-6- 
phosphatase activity either with intact microsomes or de- 
tergent-activated microsomes (not shown). Microsomal la- 
tency was in the range of 94.5-95.8%, either with control 
microsomes or microsomes pretreated with inhibitors, thus 
indicating no change in the integrity of the microsomal 
preparations in the presence of these compounds. 
2.7. Substrate spec~[icit3' studies 2.9. Statistics 
cis-Inhibition of initial UDP-GlcUA uptake by various 
UDP-sugars (UDP-GlcUA, UDP-GlcNAc, UDP-Glc and 
UDP-Xyl) and UMP was investigated at concentrations of
Values in figures and tables are given as the mean + S.E. 
of at least two independent experiments performed on two 
different microsomal preparations, unless otherwise indi- 
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cated. Testing for the significance of comparative data was 
done by the Student's t test with a confidence level of 
95%. 
3. Results 
3.1. Kinetic evidence for the presence of a multi-compo- 
nent UDP-GlcUA transporting system in rat liver endo- 
plasmic reticulum 
Transport uptake at varying concentrations of high spe- 
cific activity [13- 32 p]UDP-GlcUA determined under initial 
rate conditions (15 s incubation) provided evidence for two 
UDP-GIcUA transporting components. As shown in Fig. 1, 
a double reciprocal plot of uptake at substrate concentra- 
tions ranging from 1-110 txM substrate was biphasic, and 
an Eadie-Hofstee plot of this uptake clearly indicated the 
presence of at least two components of UDP-GlcUA trans- 
port. One was characterized by a V m of 30 + 3 pmol. 
min - l .  mg-I  and a K m of 1.6 + 0.4 IxM and is subse- 
quently referred to throughout his study as the high 
affinity component of the UDP-GlcUA uptake into micro- 
somal vesicles. The second saturable, low affinity compo- 
nent of this uptake was characterized by a V m of 163 + 23 
pmol • min-I . mg-~ and a K m of 38 4- 7 txM. Conse- 
quently, two concentrations of radiolabeled UDP-GlcUA 
were chosen to study both the high affinity and the low 
affinity components of uptake (5 p~M and 75 txM, respec- 
200 
\ 
150- \ [Km =38_+7~tM [ 
-"~. ~ ~ 6 3  -+ 23 pmoles.min-l.mg "1 
~ 100- 
~. ~ [Km = 1.6 + 0.4 ~M [ 
:.\" I I V m = 30 + 3 pmoles.min-l.mg -1 50- 
o 
5 10 15 20 
V/S (pmoles.min'l.mg'l.~M "1) 
Fig. 1. Substrate concentration-dependence of the initial uptake rate of 
[13-32p]UDP-GlcUA into ER vesicles. The initial uptake rate of radiola- 
beled UDP-GIcUA into ER vesicles (250 Ixg protein) was measured after 
15-s incubation at 25°C in a concentration range of l -110 p~M substrate 
in 0.25 M sucrose, 1 mM MgCI z, 10 mM Tris-HCl pH 7.4, by rapid 
filtration as described under Section 2. The figure is an Eadie-Hofstee 
plot of the data for one representative experiment while V m and K m 
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Fig. 2. Time and temperature-dependence of [13-32 P]UDP-GlcUA trans- 
port into ER vesicles. Initial rates of 5 ~M and 75 txM UDP-GlcUA 
uptake were measured at 4°C and 25°C in intact rat liver microsomal 
vesicles (250 ~g protein), as described under Section 2. (Inset) Initial 
time course of uptake of 5 txM and 75 bM [[3-32p]UDP-GIcUA at 25°C. 
Values represent the mean+S.E, of triplicate determinations from two 
different microsomal preparations. 
tively). The availability of high specific-activity [13- 
32 P]UDP-GlcUA allowed us to study higher substrate con- 
centrations and do faster assays than with the commer- 
cially available ~4C analog which is expensive and has low 
specific activity. Both compounds behaved in the same 
manner in preliminary studies. 
3.2. Time- and temperature-dependence of UDP-GlcUA 
uptake 
Fig. 2 shows the time-course and temperature-depen- 
dence of UDP-GlcUA transport into ER vesicles. The 
transport of 5 IxM and 75 ~M UDP-GlcUA into microso- 
mal vesicles was linear over 25 and 20 s incubations, 
respectively, at 25°C (Fig. 2, inset). Uptake measurements 
at time periods up to 60 min reached equilibrium at 20 rain 
and 40 min for the high and low affinity components, 
respectively. In both cases, uptake is followed by the 
initial 'overshoot' phenomenon due to a trans-stimulation 
effect by intravesicular UDP-sugars [11] (data not shown). 
As shown in Fig. 2, the transport of UDP-GlcUA was 
strongly temperature-dependent. The uptake rates at 1 min 
for the low and high affinity components were decreased 
by 70 and 80%, respectively, when the temperature was 
reduced from 25°C to 4°C. The uptake of [ 14 C]UDP-GIcUA 
at the same concentrations and for the same time-period as 
those described in Fig. 2, was found to be identical to that 
of [13- 32 p]UDP-GlcUA (results not shown). This observa- 
tion supports the previous finding that UDP-GlcUA, and 
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not the product of its enzymatic hydrolysis, is the substrate 
being transported [ 11 ]. 
3.3. Evidence that osmolarity affects both components of 
UDP-GlcUA uptake into ERc, esicles 
In order to distinguish between time- and temperature- 
dependent binding to the ER membranes and translocation 
of UDP-GlcUA, the influence of osmolarity on both com- 
ponents of the uptake was investigated. Uptake was mea- 
sured at equilibrium (40 min incubation at 37°C) in the 
presence of either 5 or 75 ~M UDP-GlcUA under differ- 
ing osmotic conditions (0.3-0.5 osm.kg- l ) .  [14C]UDP- 
GlcUA was used instead of [13- 32 p]UDP-GlcUA for this 
study because at 37°C UDP-GlcUA is extensively metabo- 
lized at the lumenal face of the ER. Bossuyt and Blanck- 
aert postulated that the resulting UMP, as well as Pi, is 
transported out of the ER [13], resulting in loss of the 32p 
label in the UDP moiety. It was also shown that, of the 
products of hydrolysis, the 14C-labeled glucuronic acid was 
not transported out of the ER under these conditions. Thus, 
it is necessary to use [~4C]UDP-GlcUA when the uptake is 
evaluated at 37°C and equilibrium (40 min incubation). As 
shown in Fig. 3, the uptake of the ~4C-radiolabel into the 
ER vesicles was dependent on the osmolarity of the incu- 
bation medium for both transporting components. More- 
over, plotting the uptake at the equilibrium as a function of 
1/osmolarity resulted in a linear relationship. The inter- 
cept on the y-axis allowed the determination f a binding 
component (at infinite raffinose concentration) which rep- 
resents 22.5% of the total incorporation at equilibrium. 
This is in accordance with previous work [11,12] and is 
independent of the UDP-GIcUA concentration used. As- 
suming an intravesicular volume of approximately 2
i, z l /mg protein, the internal UDP-GlcUA concentration at
equilibrium would reach about 50 IxM at an external 
UDP-GlcUA concentration of 5 txM and 425 txM at an 
external UDP-GlcUA concentration f 75 ~M [11], (Berg, 
C. and Gollan, J., unpublished observations). These values 
represent concentration gradients of 10- and 5.7-fold across 
the microsomal membrane for the high and low affinity 
components, respectively. This steady-state accumulation 
of UDP-GlcUA further supports carrier-mediated transport 
into ER vesicles. The possible driving force generating the 
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Fig. 3. Effect of osmolarity on UDP-GIcUA uptake into ER vesicles. Rat 
liver microsomes (250 ixg protein) were incubated for 15 min at 37°C in 
0.25 M sucrose, 1 mM MgCI 2, 10 mM Tris-HCl pH 7.4 and increasing 
raffinose concentrations (0-150 mM). [14C]UDP-GlcUA was then added 
at a final concentration of 5 ~M (0)  or 75 ixM (O) and uptake was 
measured, as described under Section 2. Values represent the mean __. S.E. 
of triplicate determinations from two different microsomal preparations. 
of coupling between intemal UDP-GlcNAc effiux and 
UDP-GlcUA influx [13]. 
3.4. UDP-sugars and the specificity of UDP-GlcUA uptake 
into ER vesicles 
The specificity of the UDP-GlcUA uptake for both 
components was characterized by examining cis-inhibition 
and trans-sfimulation with UDP-GlcUA, UDP-GlcNAc, 
UDP-Glc and UDP-Xyl. The effect of UDP-sugars in 
contact with the cis-face of the UDP-GlcUA transporter(s) 
(cytosolic side of the ER vesicles) was examined by 
externally adding the corresponding UDP-sugar at 0.1 mM 
and 1.0 mM concentrations, measuring the initial rate of 
UDP-GIcUA influx at 15 s and 25°C, and comparing it to 
the null cis-condition (uptake control with no competitor). 
Both components of UDP-GlcUA uptake were found to be 
inhibited in a dose-dependent manner by UDP-sugars (Ta- 
ble 1). Qualitatively, the same pattern of inhibition was 
Table 1 
cis-Inhibition by UDP-sugars of [13- t2 P]UDP-GlcUA uptake into intact rat liver microsomes 
UDP-GIcUA (mM) UDP-GlcNAc (mM) UDP-Glc (mM) UDP-Xyl (mM) 
0.1 1 0.1 1 0.1 1 0.1 1 
High affinity system (5 I.tM UDP-GclUA) 12 _+ 1 5 _+ 1 34 +_ 6 9 + 2 76 + 21 42 + 3 62 _+ 17 15 _+ 3 
Low affinity system (75 IxM UDP-GlcUA) 43 _+ 5 29 _+ 2 82 _+ 0 35 + 7 93 + 24 77 +_ 21 78 -t- 7 63 + 2 
The [13- 32 P]UDP-GlcUA uptake into ER vesicles (250 ixg proteins) was measured at 25°C after 15-s incubation in the presence of externally added 
UDP-GIcUA, UDP-GlcNAc, UDP-GIc, UDP-Xyl at 0.1 mM and 1 mM concentrations a  described under Section 2. Uptake in the absence of UDP-sugars 
was assigned as 100% (uptake control, zero cis conditions). Values represent the mean ___ S.E. of triplicate determinations from two different microsomal 
preparations. Results are expressed as % control. 
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Table 2 
trans-Stimulation by UDP-sugars of [[3 -32 P]UDP-GlcUA influx into intact rat liver microsomes 
High affinity system (5 IxM UDP-GlcUA) 
Low affinity system (75/~M UDP-GlcUA) 
UDP-GIcUA UDP-GIcNAc UDP-GIc UDP-Xyl 
0.1 1 0.1 I 0.1 1 0.1 1 
86+13 113+14 194_+59 539+6"  115_+2 132_+1" 95_+10 11l+4 
112-+7 134_+28 100_+26 232_+49 94_+11 111-+9 98-+12 114+22 
ER microsomal vesicles were preloaded with UDP-GlcUA, UDP-GlcNAc, UDP-Glc, UDP-Xyl at 0.1 mM and 1 mM concentrations throughout the 
microsomal preparations. The initial uptake of [13_32p]UDP_GIcUA (50 bg proteins) in the absence of preloaded UDP-sugars was assigned as 100% 
(control). The percentage of residual uptake (trans-stimulation) was expressed after correction for the c/s-inhibition due to extravesicular UDP-sugars 
(1.4-14 I, zM) in the incubation medium. Values represent the mean + S.E. of triplicate determinations from two different microsomal preparations. Results 
are expressed as % control. 
a significantly different from control (zero trans condition) with P < 0.05. 
observed for both transporting components, while quantita- 
tively, the high affinity component showed a stronger 
inhibition by UDP-sugars as compared to the low affinity 
system under the experimental conditions employed. After 
UDP-GIcUA,  UDP-G lcNAc  was the most potent inhibitor, 
fo l lowed by UDP-Xy l  and UDP-Glc,  suggesting that these 
compounds might be substrates (with varying affinities) 
for the transporter. It has been previously shown that 
UDP-G lcUA is a cis-inhibitor of UDP-GIc  influx and a 
trans-stimulator f the UDP-Glc  effiux [23], and these two 
UDP-sugars might thus share, at least in part, the same 
transporter. The cis-addition of non-labeled UDP-G lcUA 
led to a sharp decrease of  vesicle-associated radioactivity, 
in accordance with a carrier-mediated process for both 
uptake components (Table 1). The trans-stimulation of 
UDP-G lcUA uptake into ER vesicles by these UDP-sugars 
was investigated by preloading the vesicles (0.1 and 1.0 
mM sugar-nucleotide) and measuring the UDP-G lcUA in- 
flux relative to the proper uptake control (non-preloaded 
microsomes to which were added UDP-sugars at the con- 
centrations determined to be present at the cis-face of the 
pre-loaded microsomes during influx measurements). Of  
the nucleotide sugars tested, UDP-G lcNAc  was found to 
be the most efficient in trans-stimulating UDP-G lcUA 
import: influx of  5 IxM and 75 IxM UDP-G lcUA were 
stimulated up to 5 times and 2 times, respectively, when 
microsomal vesicles were preloaded with 1.0 mM UDP-  
Table 3 
Effect of preloading intact rat liver microsomes with UMP on the 
[13_ 32 P]UDP-GlcUA influx 
UMP (mM) 
0.1 1 
High affinity system 96_+ 19 120_+ 15 
Low affinity system (75 IzM UDP-GlcUA) 92 _+ 13 82 _+ 7 
ER microsomal vesicles were preloaded with UMP at 0. tmM and 1 mM 
concentrations throughout the microsomal preparations. The initial uptake 
of [13-32 P]UDP-GIcUA (50 txg protein) in the absence of preloaded UMP 
was assigned as 100% (control). The percentage of residual uptake was 
expressed after correction for the cis-inhibition due to extravesicular 
UMP (1.4-14 IxM) in the incubation medium. Values represent the 
mean + S.E. of triplicate determinations from two different microsomal 
preparations. Results are expressed as % control. 
G lcNAc (Table 2). UDP-Glc  and UDP-Xy l  did not show 
any significant trans-stimulatory effect, trans-Stimulation 
experiments with UMP showed no effect on either compo- 
nent of UDP-G IcUA uptake (Table 3). 
3.5. Effect of  anion-transport inhibiWrs on UDP-GlcUA 
uptake into ER vesicles 
Different classes of inhibitors were used to characterize 
both components of  the UDP-G lcUA uptake. It has been 
shown previously that SITS and DIDS inhibit the carrier- 
mediated transport of UDP-G lcUA,  i.e., what we now 
identify as the high affinity component [10,12]. In the 
present studies, we investigated the effect of SITS and 
DIDS on both uptake components in intact microsomes. 
The evaluation of IC50 values for both compounds pre- 
sented in Table 4 clearly indicates that DIDS does not 
discriminate, while the inhibition by SITS was approxi- 
mately three times more pronounced for the high affinity 
component of the uptake as compared to the low affinity 
component. 
Diuretics, such as probenecid and furosemide, are used 
widely as reversible inhibitors of  anion carriers [24]. 
Table 4 
Effect of SITS and DIDS on the uptake of [13-32 P]UDP-GIcUA into intact 
microsomes 
ICso DIDS ICso SITS 
(I~M) (~M) 
High affinity system (5 IxM UDP-GlcUA) 149_+ 19 363 + 20 " 
Low affinity system (75 t-tM UDP-GIcUA) 162 _+ 45 1106_+ 9 ~' 
Microsomal vesicles (21.3 mg proteins/ml) were incubated for 10 min 
with different concentrations of SITS (0.05-1.2 raM), DIDS (0.05-0.8 
mM) or 2% (v/v) DMSO (control) at 25°C. Microsomal vesicles were 
diluted 10 times in 0.25 M sucrose, 1 mM MgC12, 10 mM Tris-HC1, pH 
7.4 and initial rates of UDP-GIcUA uptake in intact rat liver microsomes 
were measured at 5 heM ('high affinity system') and 75 IxM ('low affinity 
system') radiolabeled UDP-GlcUA after 15-s incubation at 25°C as 
described under Section 2. ICs0 is the concentration of the irreversible 
inhibitors SITS and DIDS which causes 50% inhibition of the uptake of 5 
and 75 /,xM radiolabeled UDP-GIcUA. Values represent the mean_+ S.E. 
of triplicate determinations from two different microsomal preparations. 
" Significantly different between high and low affinity components 
(P < 0.05). 
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Fig. 4. Inhibition of the uptake of [13-32 P]UDP-GIcUA by furosemide and 
probenecid. Initial rates of UDP-GlcUA uptake in intact rat liver micro- 
somes (250 I~g protein) were measured at 5 txM and 75 IxM radiolabeled 
UDP-GIcUA after 15-s incubation at 25°C with different concentrations 
of furosemide (0.1-2 mM) or with 1 mM probenecid, as described under 
Section 2. The percentage of residual uptake is the ratio of the uptake in 
the presence of inhibitors compared to a control uptake (100%) in which 
inhibitors were omitted. Values represent the mean+S.E, of triplicate 
determinations from two different microsomal preparations. 
Therefore, the inhibition pattern of the UDP-GlcUA uptake 
by these inhibitors was determined. Fig. 4 shows the 
inhibition for the two UDP-GlcUA uptake components by 
these reversible anion-transport inhibitors. The inhibition 
by furosemide was tested at a concentration range of 
0.1-2.0 mM. The inhibitory effect of furosemide is dimin- 
ished when the uptake is performed at 75 p.M UDP-GlcUA 
compared to 5 IxM, suggesting that the low affinity com- 
ponent is less sensitive to these inhibitors than the high 
affinity component. The inhibitory effect of probenicid 
was examined only at a concentration of 1 mM due to its 
limited solubility and no inhibition was observed. 
Table 5 
Effect of AZT and AZTMP on the initial uptake rate of 5 IxM and 75 p.M 
[[3- 32 P]UDP-GIcUA into intact microsomes 
AZT (mM) AZTMP (mM) 
0.1 1 0.1 1 
High affinity system 85 +7 79+ 14 604-7 40+ 10 
(5 txM UDP-GIcUA) 
Low affinity system 985:3 96___ 1 90+3 575:3 
(75 txM UDP-GlcUA) 
The [13-32p]UDP-GlcUA uptake into ER vesicles (250 Ixg proteins) was 
measured at 25°C after 15-s incubation as described under Section 2. The 
uptake in the absence of inhibitors was assigned as 100% (control). 
Values represent the mean 5: S.E. of triplicate determinations from two 
different microsomal preparations. Results are expressed as % control. 
3.6. AZTMP inhibits UDP-GlcUA transport into the ER 
vesicles 
A recent study has shown that AZTMP, the primary 
metabolite of the chemotherapeutic agent AZT, inhibits 
protein glycosylation i Golgi membranes of CHO cells by 
competitive binding to several nucleotide-sugar carriers 
[25]. For this reason, we evaluated the possible inhibitory 
effect of AZT and AZTMP (0.1 mM and 1.0 mM) on both 
the high and low afffinity components of UDP-GlcUA 
uptake in microsomal vesicles. As shown in Table 5, AZT 
did not inhibit the uptake of either concentration f UDP- 
GlcUA. However, AZTMP exhibited a dose-dependent 
inhibition of both components of UDP-GlcUA uptake, 
with 50% inhibition in the range of 1 raM. 
4. Discussion 
Early investigations suggested that UDP-GlcUA trans- 
port is a carrier-mediated process [9]. Studies in intact ER 
vesicles have subsequently provided a functional character- 
ization of UDP-GlcUA transport [10-12]. 
The data presented here demonstrate hat in addition to 
a transport system characterized bya low Km, UDP-GIcUA 
is a substrate for at least one other transport component. 
UDP-GlcUA uptake by intact ER vesicles was mediated 
by both a high affinity (K m 1.6 IxM) and a low affinity 
(K  m 38.0 b~M) transport system, but only the high affinity 
component has been detected in previous studies [10,12]. 
Because the prior experiments were performed at UDP- 
GIcUA concentrations of 3.5-5.0 txM, the contribution of 
the low affinity component tothe transport of UDP-GIcUA 
was negligible, and the characteristics of the system de- 
scribed correspond to the high affinity transport compo- 
nent in the present studies. However, under the present 
experimental conditions, the V m of the high affinity trans- 
porting component was lower than previously described 
[12]. 
Recently, Bossuyt et al., performed extensive character- 
ization of the UDP-GlcUA uptake process in rat liver ER 
[11]. In most experiments, the average concentration of 
UDP-GlcUA used for the characterization f UDP-GlcUA 
uptake was 25 IxM; hence, this characterization f UDP- 
GIcUA uptake is likely to represent the overlapping contri- 
butions of both high and low affinity components. The 
authors were unable to provide conclusive vidence for 
two components of the transport of UDP-GlcUA, based on 
the kinetic parameters observed in those studies [11]. How- 
ever, several multi-component models for carrier-mediated 
transport of various ligands across membranes, including 
the ER, have been described previously [23,26,27]. Our 
studies indicate that the two-component system for the 
transport of UDP-GIcUA may belong to this class of 
transporters. 
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In order to present definitive proof that a new UDP- 
GIcUA transport component had been detected, it was 
necessary to document hat the transport system was an 
integral part of the ER, rather than originating from con- 
tamination by other subcellular fractions. The unavoidable 
presence of the Golgi marker enzyme, ovomucoid UDP- 
galactosyltransferase, hasbeen reported previously in ER 
preparations u ed for UDP-GIcUA transport studies [11,21 ]. 
The activity of this enzyme in our microsomal preparation 
was 4.87 + 0.19 nmol/h • mg protein and was in the range 
of previously published ata [21]. However, we have accu- 
mulated evidence which excludes the possibility that either 
of the UDP-GIcUA components originate from Golgi con- 
tamination. The functional characterization f UDP-GlcUA 
transport in Golgi vesicles and Golgi protein proteo- 
liposomes has been well-characterized [28]. The apparent 
K m of the transport was in the range of 3-5 t~M and the 
uptake was significantly stimulated by UMP. However, it 
has been shown previously that the high affinity compo- 
nent in ER vesicles, which is characterized by a K m 
similar to that observed in the Golgi vesicles, is not 
trans-stimulated by UMP [12] and this observation was 
confirmed in the course of the present study (Table 3). The 
low affinity component is characterized by an apparent K m 
value approximately ten times higher than that in Golgi 
membranes and is not trans-stimulated by UMP (Table 3). 
The Golgi transporting system is characterized by a low 
uptake rate [28], in contrast to the relatively high velocities 
of both components identified and characterized in our 
studies (Fig. 1). 
The major focus of the present studies was a detailed 
comparison of the high and low affinity transporting com- 
ponents. Substrate specificity determination, time- and 
temperature-dependence, various inhibitory studies and os- 
molarity dependence were performed simultaneously for 
both systems. Substrate specificity studies of the two com- 
ponents indicated that other UDP-sugars are cis-inhibitors 
of UDP-GIcUA uptake (Table 1). Thus, the same trans- 
porter may contribute to the translocation of other sugar 
nucleotides, possibly as an alternate transport system regu- 
lating their availability for conjugation reactions within the 
lumen of the ER. 
For more detailed comparative studies, various in- 
hibitors of anion transport were employed to further differ- 
entiate the two uptake components. Stilbene disulfonate 
derivatives, such as SITS and DIDS, covalently bind 
through their isothiocyano groups to the e-amino group of 
lysyl residues of membrane carriers. SITS and DIDS have 
a very similar structure, but DIDS possesses two reactive 
isothiocyanate groups, while SITS has only one and, thus, 
DIDS can potentially provide a cross-linkage between two 
lysyl residues. In our studies, where the ICs0 for both 
inhibitors of both components was evaluated, this property 
strengthens the inhibitory potency of DIDS compared to 
SITS (Table 4). SITS and DIDS are membrane-imper- 
meant compounds and their binding site(s) is (are) thus 
likely to be on the cytosolic face of the UDP-GlcUA 
transporter(s). Since a higher UDP-GlcUA concentration 
increases the SITS IC5o value, it is reasonable to assume 
that SITS competes with UDP-GlcUA for the same bind- 
ing site if a large fraction of its inhibitory effect is 
reversible. Such a partial reversibility of SITS binding has 
been observed for other transport systems [29]. 
Two reversible inhibitors of anion transporters, probeni- 
cid and furosemide, were tested for their ability to inhibit 
both transport components (Fig. 4). Probenicid did not 
exhibit any significant inhibition of either component, 
whereas furosemide showed a dose-dependent i hibition of 
uptake by both components. The high affinity component 
was potently inhibited, while the low affinity compound 
was less sensitive to this inhibitor in the same concentra- 
tion range, which supports a partial or total overlapping of 
the binding sites for furosemide and UDP-GIcUA. Finally, 
the effect of inhibition of UDP-GIcUA transport by AZT 
and its primary metabolite, AZTMP, were examined. It 
was shown recently that AZTMP is a potent competitive 
inhibitor of the influx of nucleotide sugars into the Golgi 
apparatus [25]. Our studies, as shown in Table 5, demon- 
strated that AZTMP, but not AZT, inhibited UDP-GlcUA 
influx into ER vesicles. Furman et al. [30] demonstrated 
that the phosphorylation f AZT is catalyzed by a cytoso- 
lic thymidine kinase, and AZTMP was found to be at a 
concentration close to I mM in a human cell line. Thus, it 
is reasonable to assume that in vivo AZTMP could inhibit 
UDP-GlcUA transport and subsequent glucuronidation re- 
actions by a partial depletion of UDP-GlcUA within the 
lumen of the ER. Moreover, AZT also inhibits the forma- 
tion of uridine nucleotides [31] involved in early stages of 
UDP-GlcUA synthesis. It has also been demonstrated that 
AZT is extensively glucuronidated in human liver micro- 
somes and competes with the glucuronidation of other 
drugs and steroid hormones [32]. Recently, we have uti- 
lized a photoaffinity analog of AZTMP in rat liver micro- 
somes to identify a 130 kDa protein that interacts with 
AZTMP and UDP-sugars [33]. Therefore, multiple effects 
of AZT and its metabolite AZTMP on UGTs and UDP- 
GlcUA transport could impair normal glucuronidation of 
endogenous and exogenous compounds. 
A long-standing question in hepatic glucuronidation is
the involvement of UDP-GlcNAc as a physiological acti- 
vator. In our studies, both components of the UDP-GIcUA 
uptake were trans-stimulated and cis-inhibited by UDP- 
GIcNAc (Tables 1 and 2). The significant trans-stimula- 
tion of both components provided strong evidence that the 
translocation of UDP-GIcUA across the ER is a facilitated 
diffusion process. More interestingly, UDP-GlcUA itself 
was not efficient in trans-stimulating the uptake compared 
to UDP-GIcNAc. Two models have been proposed for the 
carrier-mediated uptake of UDP-GlcUA into the ER. The 
first model includes a transporter with a shared specificity 
towards UDP-GlcUA and UDP-GlcNAc, and is based on 
the potent stimulatory effect of an outwardly-directed 
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UDP-GlcNAc gradient on the influx of UDP-GlcUA,  which 
suggests that the transporter might have an high affinity 
for UDP-GlcNAc.  The recently proposed second model 
includes an antiporter which couples the UDP-GlcUA 
entering the ER with the efflux of UDP-GlcNAc [13]. Our 
data supports this second model with UDP-GIcUA, UDP- 
Glc, UDP-Xyl  as cis-inhibitors but not trans-stimulators 
of UDP-GlcUA influx. This model also is supported by 
our studies where a potent cis-inhibitory/trans-stimula- 
tory effect of UDP-GIcNAc on UDP-GIcUA import (Ta- 
bles 1 and 2) was observed. However, it is premature to 
propose reliable models based on these available data. The 
identification and isolation of the protein(s) involved and 
reconstitution followed by direct transport measurements 
with both UDP-GlcUA and UDP-GIcNAc would answer 
this question definitively. 
In summary, we have provided evidence for the exis- 
tence of two UDP-GIcUA transport systems in rat liver 
ER. In general, these two components for the transport of 
UDP-GlcUA share major properties. The similarity of the 
patterns of inhibit ion of the two systems by anion-transport 
inhibitors, as well as cis-inhibition and trans-stimulation 
by UDP-sugars, suggest structurally and functionally re- 
lated transporters. As previously emphasized for other 
transport systems [26], it is unclear whether these two 
components reflect the presence of one protein with two 
affinities for UDP-GIcUA or multiple transporter proteins. 
Studies are in progress to identify the proteins involved. 
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